Log in

Relevant bibliographies by topics / Cancer Enzymes

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Cancer Enzymes'

Author: Grafiati

Published: 4 June 2021

Last updated: 6 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cancer Enzymes.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cancer Enzymes"

1

Schwartz, Morton K. "Enzymes in Cancer." Clinics in Laboratory Medicine 9, no. 4 (1989): 757–66. http://dx.doi.org/10.1016/s0272-2712(18)30603-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Tran, Luyen Van. "ID2018 Radioisotope Enzymes And Cancer Study." Biomedical Research and Therapy 4, S (2017): 51. http://dx.doi.org/10.15419/bmrat.v4is.261.

Full text

Abstract:

Cancer is a pathological symptom, when abnormal cells appear in certain human tissues or organs. These cells can reproduce beyond the control of normal biological protection mechanism. Because they multiply themselves rapidly, the metabolic process is accelerated, which causes an extreme need for energy, substrate material and catalyzing enzyme. Bases on these needs, we can control the metabolic process by: • Stopping the supply of energy. • Stopping the supply of substrate materials to build up the cell’s structure. • Stopping the catalysis process by breaking out the enzyme’s structure and/o

APA, Harvard, Vancouver, ISO, and other styles

3

Mohamed, Mona Mostafa, and Bonnie F. Sloane. "multifunctional enzymes in cancer." Nature Reviews Cancer 6, no. 10 (2006): 764–75. http://dx.doi.org/10.1038/nrc1949.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Asaduzzaman Khan, Md, Mousumi Tania, Dian-zheng Zhang, and Han-chun Chen. "Antioxidant enzymes and cancer." Chinese Journal of Cancer Research 22, no. 2 (2010): 87–92. http://dx.doi.org/10.1007/s11670-010-0087-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Pramono, Alvinsyah Adhityo, Gulam M. Rather, Herry Herman, Keri Lestari, and Joseph R. Bertino. "NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview." Biomolecules 10, no. 3 (2020): 358. http://dx.doi.org/10.3390/biom10030358.

Full text

Abstract:

Actively proliferating cancer cells require sufficient amount of NADH and NADPH for biogenesis and to protect cells from the detrimental effect of reactive oxygen species. As both normal and cancer cells share the same NAD biosynthetic and metabolic pathways, selectively lowering levels of NAD(H) and NADPH would be a promising strategy for cancer treatment. Targeting nicotinamide phosphoribosyltransferase (NAMPT), a rate limiting enzyme of the NAD salvage pathway, affects the NAD and NADPH pool. Similarly, lowering NADPH by mutant isocitrate dehydrogenase 1/2 (IDH1/2) which produces D-2-hydrox

APA, Harvard, Vancouver, ISO, and other styles

6

Marquez, Jubert, Jessa Flores, Amy Hyein Kim, et al. "Rescue of TCA Cycle Dysfunction for Cancer Therapy." Journal of Clinical Medicine 8, no. 12 (2019): 2161. http://dx.doi.org/10.3390/jcm8122161.

Full text

Abstract:

Mitochondrion, a maternally hereditary, subcellular organelle, is the site of the tricarboxylic acid (TCA) cycle, electron transport chain (ETC), and oxidative phosphorylation (OXPHOS)—the basic processes of ATP production. Mitochondrial function plays a pivotal role in the development and pathology of different cancers. Disruption in its activity, like mutations in its TCA cycle enzymes, leads to physiological imbalances and metabolic shifts of the cell, which contributes to the progression of cancer. In this review, we explored the different significant mutations in the mitochondrial enzymes

APA, Harvard, Vancouver, ISO, and other styles

7

Jabbour, H. N. "007. INFLAMMATORY PATHWAYS IN ENDOMETRIAL CANCER." Reproduction, Fertility and Development 21, no. 9 (2009): 5. http://dx.doi.org/10.1071/srb09abs007.

Full text

Abstract:

Endometrial cancer is the most common gynaecological malignancy and accounts for 5% of cancers in women (http://info.cancerresearchuk.org/cancerstats/). The majority of endometrial cancers occur in post-menopausal women and 80% of patients are diagnosed when the tumour is confined to the uterus (stage 1 disease). Many of the risk factors for developing endometrial cancer are associated with excess exposure to oestrogen unopposed by progesterone. It is well established that local inflammatory pathways contribute to the initiation and progression of endometrial cancers via the release of local m

APA, Harvard, Vancouver, ISO, and other styles

8

Bui, Quyen Thu, Jeong Hee Hong, Minseok Kwak, Ji Yeon Lee, and Peter Chang-Whan Lee. "Ubiquitin-Conjugating Enzymes in Cancer." Cells 10, no. 6 (2021): 1383. http://dx.doi.org/10.3390/cells10061383.

Full text

Abstract:

The ubiquitin-mediated degradation system is responsible for controlling various tumor-promoting processes, including DNA repair, cell cycle arrest, cell proliferation, apoptosis, angiogenesis, migration and invasion, metastasis, and drug resistance. The conjugation of ubiquitin to a target protein is mediated sequentially by the E1 (activating)‒E2 (conjugating)‒E3 (ligating) enzyme cascade. Thus, E2 enzymes act as the central players in the ubiquitination system, modulating various pathophysiological processes in the tumor microenvironment. In this review, we summarize the types and functions

APA, Harvard, Vancouver, ISO, and other styles

9

Al-Ghurabi, Batool Hassan, Abeer Khalid Yaseen, and Mohammed Imran Hamzah. "Serum Levels of Lactate Dehydrogenase and Alkaline Phosphatase Enzymes in Colorectal Cancer." Journal of Pure and Applied Microbiology 13, no. 1 (2019): 475–79. http://dx.doi.org/10.22207/jpam.13.1.53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ramarao-Milne, Priya, Olga Kondrashova, Sinead Barry, John D. Hooper, Jason S. Lee, and Nicola Waddell. "Histone Modifying Enzymes in Gynaecological Cancers." Cancers 13, no. 4 (2021): 816. http://dx.doi.org/10.3390/cancers13040816.

Full text

Abstract:

Genetic and epigenetic factors contribute to the development of cancer. Epigenetic dysregulation is common in gynaecological cancers and includes altered methylation at CpG islands in gene promoter regions, global demethylation that leads to genome instability and histone modifications. Histones are a major determinant of chromosomal conformation and stability, and unlike DNA methylation, which is generally associated with gene silencing, are amenable to post-translational modifications that induce facultative chromatin regions, or condensed transcriptionally silent regions that decondense res

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Cancer Enzymes"

1

Gunnarsson, Cecilia. "Steroid converting enzymes in breast cancer /." Linköping : Univ, 2005. http://www.bibl.liu.se/liupubl/disp/disp2005/med908s.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ardiani, Andressa. "Engineering novel suicide enzymes for improved cancer gene therapy." Pullman, Wash. : Washington State University, 2009. http://www.dissertations.wsu.edu/Dissertations/Spring2009/A_Ardiani_050609.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

McKay, Judith A. "The expression of xenobiotic metabolising enzymes in human tumours." Thesis, University of Aberdeen, 1996. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU078740.

Full text

Abstract:

The cytochromes P450 (CYPs), epoxide hydrolases (EHs) and glutathione S-transferases (GSTs) are three of the major families of enzymes involved in the metabolism of xenobiotics in the human body. Immunohistochemical analysis revealed a high frequency of expression of xenobiotic metabolising enzymes in all tumour types studied, in contrast to corresponding normal tissue which displayed only low levels of expression. Further examination of the CYP1 family was carried out by immunoblot analysis. All breast tumours studied were found to express CYP1B1, and not CYP1A1 or CYP1A2. Moreover, CYP1B1 wa

APA, Harvard, Vancouver, ISO, and other styles

4

Willmon, Candice Lynn. "Engineering enhanced enzymes for suicide gene therapy of cancer." Online access for everyone, 2006. http://www.dissertations.wsu.edu/Dissertations/Spring2006/c%5Fwillmon%5F050206.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Min, Junxia. "Sphingolipid metabolic enzymes modulate anticancer drug resistance." Diss., Columbia, Mo. : University of Missouri-Columbia, 2006. http://hdl.handle.net/10355/5899.

Full text

Abstract:

Thesis (Ph. D.)--University of Missouri-Columbia, 2006.<br>The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from title screen of research.pdf file viewed on (March 5, 2007) Vita. Includes bibliographical references.

APA, Harvard, Vancouver, ISO, and other styles

6

Wendum, Dominique. "Enzymes du métabolisme des eicosanoïdes et tumorigenèse colorectale et intestinale." Paris 6, 2004. http://www.theses.fr/2004PA066336.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

RICH, WENDY LEA. "Interrelationships Of The Estrogen-Producing Enzymes Network In Breast Cancer." The Ohio State University, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=osu1230581012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Marques, Carlos António Pascoal. "Study of tRNA modifying enzymes and codon usage bias in cancer." Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/16040.

Full text

Abstract:

Mestrado em Biologia Molecular e Celular<br>Recent evidences indicate that tRNA modifications and tRNA modifying enzymes may play important roles in complex human diseases such as cancer, neurological disorders and mitochondrial-linked diseases. We postulate that expression deregulation of tRNA modifying enzymes affects the level of tRNA modifications and, consequently, their function and the translation efficiency of their tRNA corresponding codons. Due to the degeneracy of the genetic code, most amino acids are encoded by two to six synonymous codons. This degeneracy and the biased usage of

APA, Harvard, Vancouver, ISO, and other styles

9

Ashtekar, Amruta Ashtekar. "A role for mitochondrial enzymes SDH and SOD2 in thyroid cancer." The Ohio State University, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=osu152355138828804.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mitchell, Irene Patricia. "Clinical, cellular and molecular aspects of carbohydrate metabolising enzymes in human tissues." Thesis, Open University, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294109.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Cancer Enzymes"

1

Advanced Course on Steroid Enzymes and Cancer (9th 2008 Erice, Italy). Steroid enzymes and cancer. Wiley-Blackwell, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Melton, Roger G. Enzyme-Prodrug Strategies for Cancer Therapy. Springer US, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wrba, Heinrich. Enzymes: A drug of the future : strengthening the immunological system with enzyme therapy : inflammation, rheumatism, viral diseases, cancer. Economed, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chiba International Symposium on Cancer (1994). Proteases involved in cancer: Proceedings of the Chiba International Symposium on Cancer : Chiba (Japan), November 7, 1994. Edited by Hiwasa Takaki and Suzuki Michiya. Monduzzi Editore, International Proceedings Division, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Otto, Pecher, ed. Enzymes: A drug of the future : strengthening the immunological system with enzyme therapy : inflammation, rheumatism, viral diseases, cancer. Ecomed, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kelley, William Donald. One answer to cancer: Reviewed after 32 years, 1967-1999 : with cancer cure suppressed. College of Metabolic Medicine, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Proteases and cancer: Methods and protocols. Humana, Springer, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lam, Maria Shuk Mun. Genetic polymorphisms in AH receptor and cytochrome P450 drug-metabolizing enzymes in relation to estradiol metabolism and breast cancer susceptibility. National Library of Canada, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

One answer to cancer: Reviewed after 30 years, 1967-1997 : the metabolic approach to the successful resolution of malignancy. Cancer Coalition, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Crothers, Robert. Enzyme solution: The story of Ensol. Heinrich Heine Press at Grass Creek, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Cancer Enzymes"

1

Sáez, Guillermo T., and Nuria Están-Capell. "Antioxidant Enzymes." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_7210-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sáez, Guillermo T., and Nuria Están-Capell. "Antioxidant Enzymes." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_7210.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zhang, Yuesheng. "Phase II Enzymes." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_4510.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zhang, Yuesheng. "Phase II Enzymes." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_4510-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mohanan, Sunish, and Scott Coonrod. "Peptidylarginine Deiminase Enzymes." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_7106-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mohanan, Sunish, and Scott Coonrod. "Peptidylarginine Deiminase Enzymes." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_7106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Zhang, Yuesheng. "Phase II Enzymes." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_4510.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jamieson, David, Sally A. Coulthard, and Alan V. Boddy. "Metabolism (Non-CYP Enzymes)." In Cancer Drug Discovery and Development. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9135-4_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Priolo, Carmen, Derek Oldridge, Martin Renatus, and Massimo Loda. "Targeting Deubiquitinating Enzymes." In Modulation of Protein Stability in Cancer Therapy. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-69147-3_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kensler, Thomas W., and Paul Talalay. "Inducers of Enzymes That Protect Against Carcinogens and Oxidants." In Cancer Chemoprevention. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-767-3_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cancer Enzymes"

1

Xiong, Yue. "Abstract SY38-04: Altered metabolic enzymes and metabolites in cancer." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-sy38-04.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dent, Sharon Y. R., Boyko Atanassov, Calley Hirsch, Evangelia Koutelou, and John Latham. "Abstract IA07: New functions for histone modifying enzymes." In Abstracts: AACR Special Conference on Chromatin and Epigenetics in Cancer - June 19-22, 2013; Atlanta, GA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.cec13-ia07.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sharma, Nidhi, Ashok Kumar, and Arun Chougle. "Abstract B86: Antioxidant enzymes status in carcinoma cervix patients before and after radiotherapy." In Abstracts: Frontiers in Cancer Prevention Research 2008. American Association for Cancer Research, 2008. http://dx.doi.org/10.1158/1940-6207.prev-08-b86.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

O’Toole, S., H. Melarcode, S. Elbaruni, et al. "EP926 PAD enzymes as a candidate therapeutic target in ovarian cancer." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.972.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Prager, H.-M., C. Lukas, M. Blaszkewicz, et al. "367 Prognosis of occupational bladder cancer and polymorphic xenobiotic metabolising enzymes." In 32nd Triennial Congress of the International Commission on Occupational Health (ICOH), Dublin, Ireland, 29th April to 4th May 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/oemed-2018-icohabstracts.1149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Armstrong, Scott A. "Abstract IA22: Targeting histone modifying enzymes in leukemia." In Abstracts: AACR Special Conference: Pediatric Cancer at the Crossroads: Translating Discovery into Improved Outcomes; November 3-6, 2013; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.pedcan-ia22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ruckhäberle, E., A. Rody, R. Gaetje, et al. "Prognostic and predictive value of enzymes of the sphingolipid metabolism in breast cancer." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-6014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Денисова, Дарья Андреевна. "CYCLIN-DEPENDENT KINASES CDK8 / 19 AND THEIR INFLUENCE ON THE ORIGIN AND DEVELOPMENT OF TUMOR PROCESSES." In Наука. Исследования. Практика: сборник избранных статей по материалам Международной научной конференции (Санкт-Петербург, Апрель 2020). Crossref, 2020. http://dx.doi.org/10.37539/srp290.2020.80.21.015.

Full text

Abstract:

Циклин-зависимая киназа CDK8 и её паралог, CDK19, являются ферментами, задействованными в развитии таких онкологических заболеваний, как рак молочной железы, колоректальный рак, рак простаты, острый миелоидный лейкоз и другие. The cyclin-dependent kinase CDK8 and its paralogue, CDK19, are enzymes involved in the development of oncological diseases such as breast cancer, colorectal cancer, prostate cancer, acute myeloid leukemia and others.

APA, Harvard, Vancouver, ISO, and other styles

9

Schreiber, Stuart L. "Abstract IA25: Linking genetic features of human cancers and histone-modifying enzymes for future cancer therapies." In Abstracts: AACR Special Conference on Chromatin and Epigenetics in Cancer - June 19-22, 2013; Atlanta, GA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.cec13-ia25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Coughlin, Kathleen, Thanasak Sueblinvong, Rachel Isaksson Vogel, Ravi Anchoori, and Martina Bazzaro. "Abstract POSTER-THER-1405: Targeting proteasome-associated deubiquitinating enzymes for ovarian cancer treatment." In Abstracts: 10th Biennial Ovarian Cancer Research Symposium; September 8-9, 2014; Seattle, WA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1557-3265.ovcasymp14-poster-ther-1405.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cancer Enzymes"

1

Brooks, James D. Prostate Cancer Prevention Through Induction of Phase 2 Enzymes. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada398147.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Brooks, James D. Patterns Cancer Prevention Through Induction of Phase 2 Enzymes. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada416528.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Brooks, James D. Prostate Cancer Prevention Through Induction of Phase 2 Enzymes. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada390676.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Paul, Satashree. Level of DNA Damage from Smoking in Bladder Cancer. Science Repository OÜ, 2021. http://dx.doi.org/10.31487/sr.blog.36.

Full text

Abstract:

Smoking is the most common and important risk factor for bladder cancer. The reason lying behind the fact is that – the smoke toxins accelerate other DNA damaging events and attention being focused on a family of enzymes called “APOBEC.

APA, Harvard, Vancouver, ISO, and other styles

5

Qian, David. The Role of Mitochondrial TCA Cycle Enzymes in Determining Prostate Cancer Chemosensitivity. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada605984.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Qian, David. The Role of Mitochondrial TCA Cycle Enzymes in Determining Prostate Cancer Chemosensitivity. Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada564586.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Qian, David. The Role of Mitochondrial TCA Cycle Enzymes in Determining Prostate Cancer Chemosensitivity. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada581651.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Qian, David. The Role of Mitochondrial TCA Cycle Enzymes in Determining Prostate Cancer Chemosensitivity. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada543825.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Nawaz, Zafar. Ubiquitin Pathway Enzymes: Coactivators of Nuclear Hormone Receptors and Their Role in the Development of Breast Cancer. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada397349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Nawaz, Zafar. Ubiquitin Pathway Enzymes: Coactivators of Nuclear Hormone Receptors and Their Role in the Development of Breast Cancer. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada408069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!